What is Chemisys?
Chemisys Laboratory operates as a state-of-the-art national medical laboratory. Its core specializations include genetics testing, toxicology, and the detailed analysis of micro plastics and nano plastics. The company provides critical insights into environmental contaminants, empowering healthcare providers and patients with the data needed for informed decision-making. Chemisys is committed to advancing scientific understanding in toxicology and environmental health, offering resources to comprehend the health implications of genetic predispositions and exposure to micro and nano plastics.
How much funding has Chemisys raised?
Chemisys has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Chemisys?
The substantial capital infusion, characterized as a large-scale late-stage funding, positions Chemisys for significant expansion and further development of its analytical capabilities. This strategic backing is expected to accelerate research and development in toxicology and environmental health, potentially leading to new diagnostic tools and enhanced environmental monitoring services. The company's focus on emerging contaminants like micro and nano plastics suggests a forward-looking strategy to address critical public health and environmental concerns.
See full Chemisys company page
